Authors


Christa Eans, PharmD, AAVHIP, MSPBA Candidate

Latest:

The Growth of mHealth in Specialty Pharmacy

Mobile technology has helped to facilitate communication between pharmacists, patients, and their caregivers.


Eileen Oldfield Associate Editor

Latest:

In Indiana HIV Outbreak, Pharmacists Spearhead Disease Education

Recent spike in HIV cases linked to intravenous drug use.



Joseph L. Fink, BSPharm, JD

Latest:

Revocation of Pharmacist's License Reviewed by Appellate Court

A pharmacist who does not attend his revocation hearing later appeals the decision against him.


This article was brought to you by Valeant® Dermatology

Latest:

Management of Cold Sores by Prescription

Pharmacists are in a unique position to counsel patients regarding treatment options for cold sores.


Jim Smeeding, RPh, MBA

Latest:

The Future of Specialty Pharmacy Lies in Last-Mile Care

Specialty pharmacy needs to become a results-based industry that delivers superior health outcomes.



Jaime Y. Smith, MAE

Latest:

Electronic Prescribing of Controlled Substances: A Tool to Help Promote Better Patient Care

This study presents the first information available regarding enablement and use by state and area characteristics of electronic prescribing of controlled substances by prescribers and pharmacy systems in from an e-prescribing network.



Brandeis Seymore, RPh

Latest:

The Expanding Role of New Medications in the Treatment of Type 2 Diabetes Mellitus

We examined the prevalence of use and cost impact of DPP-4 inhibitors and GLP-1 receptor agonists in people with diabetes.


David Kim, PharmD Candidate

Latest:

Another Look at Failed Alzheimer Disease Drug Trial

The exact etiology of Alzheimer's is unknown, and therefore, no cure exists.



Lindsey Hedgepeth Kennedy, PharmD, BCPS, BCPP

Latest:

Clozapine: A Primer For Pharmacists

Clozapine is an atypical antipsychotic for the treatment of schizophrenia.


Executive Vice President

Latest:

Key Takeaways from Asembia 2018

The annual Asembia Specialty Pharmacy Summit is the largest annual conference in the United States focused on specialty the specialty space.


Michael R. Agostino, RPh, BSPharm President, Amber Pharmacy

Latest:

Specialty Pharmacy: Increasing Value Through Accountability and Collaboration

This dynamic market is seeing a lot of growth, changes, and challenges. Specialty pharmacists can tackle the tough issues and raise the bar on greater levels of efficiency, accountability, and service while curtailing costs.


Dina F. Kheir, PharmD Candidate

Latest:

Being Critical as a Critical Care Pharmacist

Critical care is a rapidly expanding pharmacy specialty, and today's pharmacy student have more opportunities than ever to bceome successful critical care pharmacist.


Frank Sheppard

Latest:

Unique Considerations for Specialized Patient Populations for Pharmacies Utilizing Appointment-Based Care Models: Part 2

While there is a reasonable body of research on many of the diverse causes of medication nonadherence, there are much fewer data on the effectiveness of various interventions.


Laurie Toich, Assistant Editors

Latest:

Biosimilars May Change the Treatment Landscape for Inflammatory Diseases

Clinician and patient understanding and access considerations represent the most significant hurdles inhibiting the uptake of biosimilars for inflammatory conditions.


Sean Johnson

Latest:

UnitedHealthcare Bars Copay Coupons for Specialty Drugs

According to a report by Elsevier's Business Intelligence, UnitedHealthcare has announced that pharmacies that are participating in its Designated Specialty Pharmacy network will no longer redeem manufacturer-sponsored coupons.


Cristina Masseria, PhD

Latest:

Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial Fibrillation

This study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.


Alyssa Pirestani

Latest:

What You Need to Know about Hot Tamales Candy

Benzidine-based dyes commonly used in pharmaceuticals are also found in popular candy, which may lead to adverse health issues.




Pedram Pahlavan, PharmD, BSP

Latest:

Specialty Pharmacy By the Numbers

As specialty pharmacies continue to grow, health systems will need to evaluate whether an integrated specialty pharmacy is right for them.


Trang Ho

Latest:

Rx Product News Profile: A Closer Look at New FDA Actions: Bristol-Myers Squibb's and AstraZeneca's Onglyza

Onglyza (saxagliptin) comarketed by Bristol-Myers Squibb and AstraZeneca, is FDA-approved to improve glycemic control for the treatment of type 2 diabetes.


Heather N. Wolf, PharmD Candidate

Latest:

Pharmacists Need to Understand Law Related to Controlled Substances

The Protecting Patient Access to Emergency Medications Act of 2017 Spells Out Appropriate Dispensing Procedures.


Ryan W. Stevens, PharmD, BCIDP

Latest:

Many Platforms Offer Rapid Detection in Bloodstream Infections

Institutions should consider optimal targets, testing volumes, and notification and reporting practices when making their choice.



Kenneth Bender

Latest:

Inconsistent Prior Authorization Affects Attention-Deficit/Hyperactivity Disorder Treatment

Study finds that ADHD treatment recommendations are not always followed.


Michelle Whirl-Carrillo, PhD

Latest:

Pharmacogenetic Resources: PharmGKB and Clinical Pharmacogenetics Implementation Consortium

Pharmacogenetics is the study of how genes impact drug response, an integral part of personalized medicine.